Revenue | ₹1,050.76Cr |
Net Profits | ₹63.48Cr |
Net Profit Margins | 6.04% |
Akums Drugs & Pharmaceuticals Ltd’s revenue jumped 2.45% since last year same period to ₹1,050.76Cr in the Q1 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -2.83% fall in its revenue since last 3-months.
Akums Drugs & Pharmaceuticals Ltd’s net profit jumped 5.5% since last year same period to ₹63.48Cr in the Q1 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -57% fall in its net profits since last 3-months.
Akums Drugs & Pharmaceuticals Ltd’s net profit margin jumped 2.98% since last year same period to 6.04% in the Q1 2025-2026. On a quarterly growth basis, Akums Drugs & Pharmaceuticals Ltd has generated -55.75% fall in its net profit margins since last 3-months.
The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q1 results 2025 was ₹1,050.76Cr.
The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q1 results 2025 was ₹63.48Cr.
The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q1 results 2025 was 6.04%.
The revenue for Akums Drugs & Pharmaceuticals Ltd in the Q1 results 2024 was ₹1,025.66Cr.
The net profit for Akums Drugs & Pharmaceuticals Ltd in the Q1 results 2024 was ₹60.17Cr.
The net profit margin for Akums Drugs & Pharmaceuticals Ltd in the Q1 results 2024 was 5.87%.